RELAFEN TABLETS 500MG
RELAFEN TABLETS 500MG
Discontinued
DIN Number
02083531
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02083531
AIG Number0122821001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AX01 NABUMETONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
NABUMETONEActive
Strength: 500 MG
Monograph: NABUMETONE